Introduced
by
To allow lawsuits that could have been brought against makers of FDA-approved drugs before a tort reform law passed in 1995 banned such suits, to be brought for up to three years after a repeal of that law proposed by Senate Bill 132.
Referred to the Committee on Government Operations
